New President Of Ono Pharmaceutical Looks To Expand Overseas
This article was originally published in PharmAsia News
Executive Summary
Ono Pharmaceutical names current Managing Director and Director of Research Headquarters Daikichi Fukushima, as its new president effective June 27th. Current President Toshiharu Korekane will resign for health reasons and will become a special advisor to the company. Fukushima joined the company in 1978 after receiving a PhD in natural science from Tsukuba University. He became the director of research in 2006. Fukushima commented on his intention to further expand into overseas markets and promote drug development in the U.S. and Europe. Fukushima said after two years, Ono will have more overseas projects than domestic projects. (Click here for more - Japanese language)